Changes In LXRα Phosphorylation Promote A Novel Diet-Induced Transcriptome That Alters The Transition From Fatty Liver To Steatohepatitis
Natalia Becares, Matthew C Gage, Lucia Martin-Gutierrez, Elina ShresthaiD, Rikah Louie, Benoit Pourcet, Oscar M Pello, Tu Vinh Luong, Saioa Goñi, Ning Liang, Cesar Pichardo, Hanne Røberg-Larsen, Vanessa Diaz, Knut R. Steffensen, Michael J. GarabedianiD, Krista Rombouts, Eckardt Treuter, Inés Pineda-Torra
Abstract
Understanding the transition from fatty liver or steatosis to more advanced inflammatory and fibrotic stages of non-alcoholic fatty liver disease (steatohepatitis), is key to define strategies that alter or even reverse the progression of this pathology. The Liver X Receptor alpha (LXR) controls hepatic lipid homeostasis and inflammation. Here we show that mice carrying a mutation that abolishes phosphorylation at Ser196 (S196A) in LXR exhibit reduced hepatic inflammation and fibrosis when challenged with a high fat-high cholesterol diet, despite displaying enhanced hepatic lipid accumulation. This protective effect is associated with reduced cholesterol accumulation, a key promoter of lipid-mediated hepatic damage. Reduced steatohepatitis in S196A mice involves the reprogramming of the liver transcriptome by promoting diet-induced changes in the expression of genes involved in endoplasmic reticulum stress, extracellular matrix remodelling, inflammation and lipid metabolism. Unexpectedly, changes in LXR phosphorylation uncover novel diet-specific target genes, whose regulation does not simply mirror ligand-induced LXR activation. These unique LXR phosphorylation-sensitive, diet-responsive target genes are revealed by promoting LXR occupancy and cofactor recruitment in the context of a cholesterol-rich diet. Therefore, LXR phosphorylation at Ser196 critically acts as a novel nutritional sensor that promotes a unique diet-induced transcriptome thereby modulating metabolic, inflammatory and fibrotic responses important in the transition to steatohepatitis.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A Novel Mutation in LXRalpha Uncovers a Role for Cholesterol Sensing in Limiting Metabolic Dysfunction-Associated Steatohepatitis (MASH).
Alexis T. Clark, Lillian Russo-Savage, … Ira G. Schulman·Nature CommunicationsPeer-reviewed·Jan 28, 2025
- Inhibiting LXRα Phosphorylation in Hematopoietic Cells Reduces Inflammation and Attenuates Atherosclerosis and Obesity
Maud Voisin, Elina Shrestha, … Michael J. Garabedian·Communications BiologyPeer-reviewed·Mar 26, 2021
- Damaging mutations in LXRα uncouple lipogenesis from hepatotoxicity and implicate hepatic cholesterol sensing in human liver health
Sam M. Lockhart, Milan Mušo, … Stephen O’Rahilly·bioRxiv·Apr 28, 2024
- (Pro)Renin Receptor Antagonism Attenuates High-Fat-Die-Induced Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease
A. J. B. Gayban, L. Souza, … Y. Feng Earley·bioRxiv·Sep 7, 2022
- ARID1a protects against steatosis and insulin resistance via PPARalpha-mediated fatty acid oxidation
Yu-Lan Qu, Chuan-Huai Deng, … Ze-Guang Han·bioRxiv·Jan 9, 2019
- Disrupting myeloid-specific LXRα phosphorylation promotes FoxM1 expression and modulates atherosclerosis by inducing macrophage proliferation
M. C. Gage, N. Becares-Salles, … I. Pineda Torra·bioRxiv·Dec 4, 2017